Ligand-based molecular modeling study on a chemically diverse series of cholecystokinin-B/gastrin receptor antagonists: generation of predictive model.
Pharmacophore hypotheses were developed for six structurally diverse series of cholecystokinin-B/gastrin receptor (CCK-BR) antagonists. A training set consisting of 33 compounds was carefully selected. The activity spread of the training set molecules was from 0.1 to 2100 nM. The most predictive pharmacophore model (hypothesis 1), consisting of four features, namely, two hydrogen bond donors, one hydrophobic aliphatic, and one hydrophobic aromatic feature, had a correlation (r) of 0.884 and a root-mean-square deviation of 1.1526, and the cost difference between null cost and fixed cost was 81.5 bits. The model was validated on a test set consisting of six different series of 27 structurally diverse compounds and performed well in classifying active and inactive molecules correctly. This validation approach provides confidence in the utility of the predictive pharmacophore model developed in this work as a 3D query tool in the virtual screening of drug-like molecules to retrieve new chemical entities as potent CCK-BR antagonists. The model can also be used to predict the biological activities of compounds prior to their costly and time-consuming synthesis.
Chopra
Madhu
M
Laboratory of Molecular Modeling & Drug Design, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India. madhu_india04@rediffmail.com
Mishra
Anil K
AK
D000465:Algorithms; D001185:Artificial Intelligence; D016208:Databases, Factual; D008024:Ligands; D008958:Models, Molecular; D011237:Predictive Value of Tests; D043887:Receptor, Cholecystokinin B / Q000037:antagonists & inhibitors*; D015203:Reproducibility of Results
D008024:Ligands; D043887:Receptor, Cholecystokinin B